<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2007-02-22</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001333763</issuerCik>
        <issuerName>Chelsea Therapeutics International, Ltd.</issuerName>
        <issuerTradingSymbol>CHTP</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001391844</rptOwnerCik>
            <rptOwnerName>Friedman Avram Z</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O DAVIDSON KEMPNER PARTNERS</rptOwnerStreet1>
            <rptOwnerStreet2>65 EAST 55TH STREET 19TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10022</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2007-02-22</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>P</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>30800</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>6.12</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>2029300</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Notes</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                    <footnoteId id="F4"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The shares of Common Stock to which this note relates are held directly by Davidson Kempner Partners, a New York limited
 partnership (&quot;DKP&quot;), as to 55,147 shares of Common Stock (&quot;Shares&quot;); Davidson Kempner Institutional Partners, L.P., a
 Delaware limited partnership (&quot;DKIP&quot;), as to 188,469 Shares; M.H. Davidson &amp; Co., a New York limited partnership (&quot;CO&quot;), as
 to 17,339 Shares; Davidson Kempner International, Ltd., a British Virgin Islands corporation (&quot;DKIL&quot;), as to 323,901 Shares;
 Davidson Kempner Healthcare Fund LP, a Delaware limited partnership (&quot;DKHF&quot;), as to 702,199 Shares; Davidson Kempner
 Healthcare International Ltd., a Cayman Islands corporation (&quot;DKHI&quot;), as to 734,979 Shares; and as to 7,266 Shares held in a
 separately managed account.</footnote>
        <footnote id="F2">MHD Management Co., a New York limited partnership (&quot;MHD&quot;), is the general partner of DKP. Davidson Kempner Advisers Inc., a
 New York corporation (&quot;DKAI&quot;), is the general partner of DKIP and is registered as an investment adviser with the U.S.
 Securities Exchange Commission. Davidson Kempner International Advisors, L.L.C., a Delaware limited liability company
 (&quot;DKIA&quot;), is the investment manager of DKIL and a managed account. DK Group LLC, a Delaware limited liability company
 (&quot;DKG&quot;), is the general partner of DKHF. DK Management Partners LP, a Delaware limited partnership (&quot;DKMP&quot;), is the
 investment manager of DKHI.</footnote>
        <footnote id="F3">Thomas L. Kempner, Jr., Marvin H. Davidson, Stephen M. Dowicz, Scott E. Davidson, Michael J. Leffell, Timothy I. Levart,
 Robert J. Brivio, Jr., Eric P. Epstein, Anthony A. Yoseloff and Avram Z. Friedman (collectively, the &quot;Principals&quot;) are the
 general partners of CO and MHD, the sole managing members of DKIA and DKG and the sole stockholders of DKAI.  Each of
 Messrs. Kempner, Levart, Marvin H. Davidson, Dowicz, Scott E. Davidson, Leffell, Brivio, Yoseloff, Epstein and Friedman are
 limited partners of DKMP. In addition, Robert J. Brivio controls 750 Shares in a personal account for the benefit of Robert
 J. Brivio and Sophia Brivio.</footnote>
        <footnote id="F4">Each of the Reporting Persons disclaims beneficial ownership of the securities to which this Form 4 relates except to the
 extent each may be deemed to have a pecuniary interest in such securities pursuant to Section 16 of the Securities Exchange
 Act of 1934, as amended.</footnote>
    </footnotes>

    <remarks>This is Part Three of a three part Form 4 filing.  Part one is filed by Davidson Kempner Partners.  Part Two is filed by
 Thomas L. Kempner, Jr.  Parts Two and Three are filed to indicate all Reporting Persons.  Parts Two and Three are not
 separate Form 4
 filings.</remarks>

    <ownerSignature>
        <signatureName>AVRAM Z. FRIEDMAN,  /s/ Avram Z. Friedman</signatureName>
        <signatureDate>2007-03-05</signatureDate>
    </ownerSignature>
</ownershipDocument>
